A 61-year-old Ghanaian woman presented with dizziness and low oxygen saturations whereupon a methaemoglobin level of 24.9% was obtained. Initially it was thought to be caused by an unknown toxin. However, failure to normalise spontaneously and a short recurrence following administration of methylene blue suggested a congenital cause. Subsequently a novel variant in the CYB5R3 gene, coding for Cytochrome b5 reductase, was demonstrated. Absence of polycythaemia prompted additional analysis for a concomitant haemoglobinopathy.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Congenital Methemoglobinemia: A Cause of Polycythemia.
Indian J Pediatr
January 2025
Department of Clinical Hematology, SKIMS, Srinagar, Jammu and Kashmir, India.
A Case of Acquired Methemoglobinemia Following Sentinel Lymph Node Dye With Patent Blue V.
Cureus
November 2024
Department of Anesthesiology and Intensive Care, Celal Bayar University Training and Research Hospital, Manisa, TUR.
Methemoglobinemia is a rare but potentially life-threatening condition in which hemoglobin is oxidized, impairing the oxygen-carrying capacity. While congenital forms exist, acquired methemoglobinemia can occur in perioperative settings, especially following exposure to oxidizing agents such as dyes used in sentinel lymph node biopsy (SLNB). Patent Blue V, a synthetic aniline dye commonly used for SLNB, has been associated with rare but serious adverse effects, including methemoglobinemia.
View Article and Find Full Text PDFLife-Threatening Methaemoglobinaemia Secondary to Cetrimide.
Eur J Case Rep Intern Med
September 2024
Department of Medicine, Division of Pulmonary and Critical Care Medicine, Mount Lebanon Hospital Balamand University Medical Center, Beirut, Lebanon.
Article Synopsis
- * The condition is characterized by oxidized hemoglobin (ferric state), leading to symptoms like low blood oxygen levels, hypoxia, and distinct chocolate-colored blood.
- * A case study highlights how cetrimide, used in abdominal surgeries for hydatid cysts, can trigger severe methaemoglobinaemia, which often goes undiagnosed but has a high risk of mortality.
Dyskinetic Movement Disorder in Congenital Methemoglobinemia Type II.
Mov Disord Clin Pract
November 2024
Department of Pediatrics, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Management of Congenital Methemoglobinemia in the Perioperative Setting: A Case Report and Review of Current Literature.
J Blood Med
August 2024
Department of Anesthesiology, Critical Care and Perioperative MedicineHamad Medical Corporation, Doha, Qatar.
Article Synopsis
- - Methemoglobinemia is a condition where hemoglobin is oxidized, preventing it from binding oxygen, leading to symptoms like cyanosis and potential heart failure; it can be congenital or acquired, with the congenital form being rare.
- - A case study of a 22-year-old man with congenital methemoglobinemia demonstrated the need for careful perioperative management during dental surgery, including avoiding certain anesthetics and ensuring appropriate oxygenation levels.
- - Effective management of congenital methemoglobinemia during surgery requires preoperative assessment, multidisciplinary care, avoidance of oxidizing agents, and strategies to maintain the patient's oxygenation and cardiovascular stability.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!